Guidelines on nutritional management in Japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma

Hepatology Research

Volumn 42, Issue 7, 2012, Pages 621-626

  Suzuki, Kazuyuki ^a   Endo, Ryujin ^a   Kohgo, Yutaka ^c   Ohtake, Takaaki ^c   Ueno, Yoshiyuki ^d   Kato, Akinobu ^b   Suzuki, Kazutomo ^e   Shiraki, Ryo ^f   Moriwaki, Hisataka ^f   Habu, Daiki ^g   Saito, Masaki ⁱ   Nishiguchi, Shuhei ⁱ   Katayama, Kazuhiro ^h   Sakaida, Isao ^j  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Morioka Municipal Hospital   (Japan)

^c HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e DOKKYO MEDICAL UNIVERSITY   (Japan)

^f GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Osaka Prefecture University   (Japan)

^h OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

ⁱ HYOGO COLLEGE OF MEDICINE   (Japan)

^j YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Hepatocellular carcinoma; Liver cirrhosis; Malnutrition; Nutrition; Protein energy malnutrition

Indexed keywords

FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANTHROPOMETRY; ARTICLE; CANCER PREVENTION; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); DIET THERAPY; EXPERIMENTAL STUDY; FATTY ACID BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; JAPANESE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; NUTRITION; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 84862255489     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.00990.x     Document Type: Article

References (40)

1. Caregaro L, Alberino F, Amodio P etal. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr 1996; 63: 602-9.
2. Campillo B, Richardet JP, Scherman E, Bories PN. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition 2003; 19: 515-21.
3. Cabré E, Gassull MA. Nutrition in liver disease. Curr Opin Clin Nutr Metab Care 2005; 8: 545-51.
4. Riggio O, Angeloni S, Ciuffa L etal. Malnutrition is not related to alterations in energy balance in patients with stable liver cirrhosis. Clin Nutr 2003; 22: 553-9.
5. Tajika M, Kato M, Mohri H etal. Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 2002; 18: 229-34.
6. Guglielmi FW, Panella C, Buda A etal. Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the "Nutritional Problems in Gastroenterology" Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis 2005; 37: 681-8.
7. Tsiaousi ET, Hatzitolios AI, Trygonis SK, Savopoulos CG. Malnutrition in end stage liver disease: recommendations and nutritional support. J Gastroenterol Hepatol 2008; 23: 527-33.
8. Shiratori Y, Shiina S, Imamura M etal. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 1995; 22: 1027-33.
9. Kiyosawa K, Umemura T, Ichijo T etal. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 2004; 127: S17-26.
10. Michitaka K, Nishiguchi S, Aoyagi Y etal. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol 2010; 45: 86-94.
11. Nagaoki Y, Hyogo H, Aikata H etal. Recent trend of clinical features in patients with hepatocellular carcinoma. Hepatol Res 2011; doi: 10.1111/j.1872-034X.2011.00929.x.
12. Ikai I, Arii S, Okazaki M etal. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 2007; 37: 676-9.
13. Kudoh M, Arii S, Ikai I etal. The nationwide report registered every 2 years by the Liver cancer Study Group of Japan (in Japanese with English abstract). Kanzo 2007; 48: 117-40.
14. Kumada H, Okanoue T, Onji M etal. Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan. Hepatol Res 2010; 40: 1-7.
15. Kumada H, Okanoue T, Onji M etal. Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatol Res 2010; 40: 8-13.
16. Shimada M, Hashimoto E, Tasniai M etal. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Hepatol 2002; 48: S104-12.
17. Yoshiike N, Lwin H. Epidemiological aspects of obesity and NASH/NAFLD in Japan. Hepatol Res 2005; 33: 77-82.
18. Hashimoto E, Yatsuji S, Tobari M etal. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 2009; 44 (Supple XIX): 89-95.
19. Marchesini G, Bianchi G, Merli M etal. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003; 124: 1792-801.
20. Muto Y, Sato S, Watanabe A etal. Effects of oral branched chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 705-13.
21. Muto Y, Sato S, Watanabe A etal. Overweight and obesity increases the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 2006; 35: 204-14.
22. Kuroda H, Kasai K, Kakisaka K etal. Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma. Hepatol Res 2010; 40: 550-54.
23. Watanabe A, Moriwaki H, Kato A, Teramoto F. Consensus of nutritional assessments and therapies in liver diseases. Eiyo-Hyoka to. Chiryo 2003; 20: 181-96 (in Japanese).
24. Plauth M, Cabre E, Riggio O etal. ESPEN guidelines on enteral nutrition: liver disease. Clin. Nutrition 2006; 25: 285-94.
25. Plauth M, Cabre E, Campillo O etal. ESPEN guidelines on parenteral nutrition: hepatology. Clin Nutr 2009; 28: 436-44.
26. Imawari M, Fukui H, Moriwaki H etal. Nutritional therapy. In: the Japanese Society of Gastroenterology, ed. Clinical Practice Guidelines for the Management of Liver Cirrhosis, 1st edn. Tokyo: Nankodo, 2010; 22-33 (in Japanese).
27. Terakura Y, Shiraki M, Nishimura K etal. Indirect calorimetry and anthropometry to estimate energy metabolism in patients with liver cirrhosis. J Nutr Sci Vitaminol (Tokyo) 2010; 56: 372-9.
28. Shiraki M, Terakura Y, Iwasa J etal. Elevated serum tumor necrosis factor-alpha and soluble tumor necrosis factor receptors correlate with aberrant energy metabolism in liver cirrhosis. Nutrition 2010; 26: 269-75.
29. Suzuki K, Takikawa Y. Biomarkers of malnutrition in liver cirrhosis. In: Preedy VR, Lakshman R, Srirajaskanthan R etal., eds. Nutrition, Diet Therapy, and the Liver. London: CRC Press, 2009; 203-15.
30. Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol 2008; 88: 7-15.
31. Kohgo Y, Ohtake T, Ikuta K, Suzuki Y, Torimoto Y, Kato J. Dysregulation of systemic iron metabolism in alcoholic liver disease. J Gastroenterol Hepatol 2008; 23: S78-81.
32. Kakazu E, Ueno Y, Kondo Y etal. Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis. Hepatology 2009; 50: 1936-45.
33. Korenaga K, Korenaga M, Uchida K, Yamasaki T, Sakaida I. Effects of a late evening snack combined with alpha-glucosidase inhibitor on liver cirrhosis. Hepatol Res 2008; 38: 1087-97.
34. Harima Y, Yamasaki T, Hamabe S etal. Effect of a late evening snack using branched-chain amino acid-enriched nutrients in patients undergoing hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma. Hepatol Res 2010; 40: 574-84.
35. Suzuki K, Kagawa K, Koizumi K, Suzuki K, Katayama H, Sugawara M. Effects of late evening snack on diurnal plasma glucose profile in patients with chronic viral liver disease. Hepatol Res 2010; 40: 887-93.
36. Habu D, Nishiguchi S, Nakatani S etal. Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis. Hepato-Gastroenterology 2009; 56: 1719-23.
37. Kawamura E, Habu D, Morikawa H etal. A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status. Liver Transpl 2009; 15: 790-97.
38. Iwasa J, Shimizu M, Shiraki M etal. Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. Cancer Sci 2010; 101: 460-7.
39. Moriwaki H, Aoyagi S, Ishizuka Y etal. Japanese Anthropometric Reference Data 2001. Osaka: Medical Review, 2002.
40. Kawano Y, Ando K, Matsuura H, Tsuchihashi T, Fujita T, Ueshima H. Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (1) Rationale for salt restriction and salt-restriction target level for the management of hypertension. Hypertens Res 2007; 30: 879-86.